np event 2254995 0E193A 1 1
Sep 13, 2026
The New Era of Biologic Therapies to Improve Outcomes in Patients With Severe Asthma
CME Symposium at the 2026 Eastern Pulmonary Conference

Date/Time

Sunday, September 13th, 2026
From 12:15pm – 1:00pm EDT

Location

The Breakers Palm Beach

Ponce de Leon 1 & 2

1 S County Rd

Palm Beach, FL 33480

Target Audience

Pulmonologists and their care teams, other internists, primary care providers, and other healthcare professionals who contribute to the management of patients with severe asthma.

Financial Support

This activity is supported by an independent educational grant from GSK.

Accreditation Statement

Joint
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Credit Designation Statements

AcademicCME designates this live material for a maximum of 0.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Supporter Statement

This activity is supported by an independent educational grant from GSK.

For further conference information or questions, email admin@academiccme.com.

Event Details

CE Inquiries/Special Needs

1

Review the multiple pathophysiologic mechanisms including the role of IL-5 in type 2 inflammation, which may contribute to the development and persistence of severe asthma.

2

Discuss the standard of care for the diagnosis and timely initiation of evidence-based treatment of severe asthma, including approved and emerging IL-5 therapies to minimize exacerbations.

3

Address patient comorbidities and their impact on asthma-related outcomes.

4

Develop strategies to identify and address barriers including healthcare disparities and inequities to the optimal care of patients with severe asthma through patient education and shared decision making.

Faculty

Reynold A. Panettieri Jr headshot
Reynold A. Panettieri, Jr., MD
Professor of Medicine, Robert Wood Johnson Medical School, Vice Chancellor, Clinical & Translational Science, Director, Rutgers Institute for Translational Medicine & Science, Emeritus Professor of Medicine, University of Pennsylvania, New Brunswick, NJ

Faculty

Reynold A. Panettieri Jr headshot
Reynold A. Panettieri, Jr., MD
Professor of Medicine, Robert Wood Johnson Medical School, Vice Chancellor, Clinical & Translational Science, Director, Rutgers Institute for Translational Medicine & Science, Emeritus Professor of Medicine, University of Pennsylvania, New Brunswick, NJ
Reynold A. Panettieri Jr headshot
Reynold A. Panettieri, Jr., MD
Professor of Medicine, Robert Wood Johnson Medical School, Vice Chancellor, Clinical & Translational Science, Director, Rutgers Institute for Translational Medicine & Science, Emeritus Professor of Medicine, University of Pennsylvania, New Brunswick, NJ

Event Registration